Epidemic outbreak of interstitial lung disease in aerographics textile workers--the "Ardystil syndrome": a first year follow up

Solé, A.; Cordero, P. J.; Morales, P.; Martínez, M. E.; Vera, F.; Moya, C.
January 1996
Thorax;Jan1996, Vol. 51 Issue 1, p94
Academic Journal
journal article
No abstract available.


Related Articles

  • Gefitinib.  // Reactions Weekly;11/6/2010, Issue 1326, p19 

    This article describes a case study involving a 77-year-old woman who developed interstitial lung disease following treatment with gefitinib for lung adenocarcinoma.

  • Azacitidine.  // Reactions Weekly;5/26/2012, Issue 1403, p9 

    The article describes the case of a 56-year-old man who received azacitidine for hypoplastic myelodysplastic syndrome, but developed interstitial lung disease during treatment.

  • Nifedipine.  // Reactions Weekly;7/14/2012, Issue 1410, p31 

    The article describes the case of a 76-year-old woman who developed an exacerbation of interstitial lung disease during treatment with oral nifedipine for Raynaud syndrome.

  • Nifedipine.  // Reactions Weekly;6/14/2012, Issue 1410, p31 

    The article describes the case of a 76-year-old woman who developed an exacerbation of interstitial lung disease while receiving oral nifedipine for Raynaud syndrome.

  • Interstitial Lung Disease in a Child with Antisynthetase Syndrome. Hayes, Don; Baker, Peter; Mansour, Heidi; Peeples, Mark; Nicol, Kathleen // Lung;Aug2013, Vol. 191 Issue 4, p441 

    Introduction: Antisynthetase Syndrome is associated with interstitial lung disease in adult patients, but this has not been described in children. Materials and methods: A 13-year-old with interstitial lung disease due to Antisynthetase Syndrome and pulmonary arterial hypertension underwent...

  • Rituximab.  // Reactions Weekly;Dec2014, Vol. 1532 Issue 1, p174 

    The article discusses a case study of a 30-year-old man who developed interstitial lung disease following the administration of rituximab.

  • Pirfenidone.  // Reactions Weekly;1/23/2016, Vol. 1585 Issue 1, p211 

    The article describes the case of a 66-year-old woman who developed heartburn following the treatment of pirfenidone for scleroderma-related interstitial lung disease.

  • Execs re-pack their bags for Asia.  // Home Textiles Today;6/16/2003, Vol. 24 Issue 40, p1 

    Reports on the impact of the severe acute respiratory syndrome (SARS) epidemic on the home textile industry in China. Decision of the U.S. Center for Disease Control and Prevention to downgrade notifications for Hong Kong; Resumption of the travel of home textiles executives; Views of Neil...

  • Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report. Nguyen, Hien; Le, Connie; Nguyen, Hanh // Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1 

    Introduction: Dermatomyositis has been described in the setting of lyme infection in only nine previous case reports. Although lyme disease is known to induce typical clinical findings that are observed in various collagen vascular diseases, to our knowledge, we believe that our...

  • Cases Diagnosed with Swyer James Macleod Syndrome in Adulthood. Aksoy, Emine; Aktaş, Oğuz; Tokgöz, Fatma; Kongar, Nilufer; Gökşenoğlu, Nezihe; Bodur, Yasemin; Güran, Salih; Sevim, Tülin // Turk Toraks Dergisi / Turkish Thoracic Journal;Jan2015, Vol. 16 Issue 1, p36 

    Swyer-James-MacLeod syndrome or unilateral hyperlucent lung syndrome is a rare disease characterised by hypoplasia of the pulmonary artery, unilateral hyperlucent lung and usually bronchiectasis. The syndrome was first described by Swyer and James in 1953 in a child case, and in the following...


Read the Article


Sign out of this library

Other Topics